D. Jas

发表

Adjuvant immunotherapy of feline injection-site sarcomas with the recombinant canarypox virus expressing feline interleukine-2 evaluated in a controlled monocentric clinical trial when used in association with surgery and brachytherapy

P. Devauchelle, D. Jas, C. Soyer, 2015 .

Stimulation of airway neutrophils following dexamethasone administration and equid herpesvirus-2 challenge in horses.

D. Jas, P. Lekeux, S. Pronost, 2014, Veterinary journal.

A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines.

H. Schoon, P. Devauchelle, D. Jas, 2007, Vaccine.

Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.

D. Jas, H. Poulet, S. Brunet, 2008, Vaccine.

Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.

D. Jas, P. Guigal, H. Poulet, 2012, Vaccine.

Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.

D. Jas, D. Vernes, P. Guigal, 2015, Veterinary microbiology.

Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.

D. Jas, H. Poulet, A. Guiot, 2009, Veterinary journal.

Evaluation of safety and immunogenicity of feline vaccines with reduced volume.

D. Jas, F. Oberli, P. Guigal, 2021, Vaccine.

A Nosocomial Outbreak of Feline Calicivirus Associated Virulent Systemic Disease in France

D. Jas, H. Poulet, S. Brunet, 2009, Journal of feline medicine and surgery.